About
Truvante is a science and technology consultancy and minority woman-owned small business (WOSB).
We envision better, healthier lives in a safer, sustainable world.
Our mission is to be the premier partner of the government and industry by developing and applying data-powered, person-centered, mission-focused holistic approaches to improve health, safety, and well-being for all.
Truvante was founded on the core values of Trust and Innovation.
- Trusted partner in science and technology consulting
- Mission-driven solutions for better health and safety outcomes
- Dedicated to advancing Team Science in our corporate culture, business operations, and growth
Our Services
Emerging Data Science & Technologies
- Data Governance, Standards Development, Sharing, Analytics & Visualization
- ETL Processing, SQL, NoSQL
- AI/ML Solutions
- Digital Health Technologies
- Digital Twins, Predictive Analytics
- Biometrics, Digitial Biomarkers
- Robotic Process Automation
- High-Performance Computing
Biomedical Research, Informatics, and Product Development Management
- Full-cycle scientific, informatics, and digital health research and development program management
- Program Strategy, Design, Initiation
- Personnel Training
- Budget & Operations
Digital Transformation
- Business Agility: Enhance agility, reduce cost, and gain a competitive through technology
- Customer Engagement: Reimage service delivery and engagement strategies
Infrastructure Management
- Network Design& Management
- Server Performance & Optimization
- Data Storage Solutions
- Data Center Operations: Streamlined and optimized for efficiency
Managed Services
- Scalable Infrastructure as a Service (IaaS) solutions
- 24/7 Service Desk Support
- Scientific-IT: Specialized IT services for R&D and scientific instrumentation.
- Data Governance & Privacy Compliance
- Business Continuity & Resiliency: Strategies for Operational Stability During Disruptions
- Software Configuration, Testing, and DevOps
Cybersecurity
- Comprehensive Operations & Risk Assessments
- Incident Response & Recovery Plans
- Supply Chain & Technology Risk Management
Cloud & Architecture Services
- Cloud strategy and Adoption
- Seamless migration & implementation
- System Architecture, Design, and Integration
- Requirements Capture & Analysis
Web Development & SOA/Enterprise Development
- Web services development
- Enterprise Java Technologies
- Legacy System Modernization
- GUI development
Business Growth Services
- Business Development Strategy
- Customer Engagement & Pipeline Development
- Capture, Proposal, Pricing, and Grant Development
Projects
News & Insights
October 1, 2024
October is ADHD Awareness Month
Each October, this month is dedicated to spotlighting ADHD (Attention-Deficit/Hyperactivity Disorder). An estimated 7 million (11.4%) U.S. children aged 3–17 years have been diagnosed with ADHD, according to a 2022 national survey of parents. The lifetime prevalence of ADHD stands at 8.1%.
Among those undiagnosed or untreated, ADHD is often a quiet struggle, coupled with its stigma and isolation.
Together with our community, Truvante celebrates the challenges, resilience, and triumphs of those affected by ADHD. Please join us in spreading awareness, offering support, and driving meaningful change through trust and innovation.
Resources:
August 31, 2024
Publication on Potential Liver Cancer Immunotherapy Targets in support of NCI, NIH
Congratulations to Dr. Mitchel Ho, Senior Investigator, Deputy Chief, Laboratory of Molecular Biology, and Head of Antibody Therapy Section at the Center for Cancer Research, National Cancer Institute, National Institutes of Health, on the acceptance of the manuscript entitled A Proteomic Atlas of Glypican-3 Interacting Partners: Identification of AFP and Other Extracellular Proteins as Potential Immunotherapy Targets in Liver Cancer" for publication in Proteoglycan Research.
This groundbreaking publication results from a long-term collaboration between Dr. Ho, his laboratory staff, and Truvante’s Founder. We at Truvante are proud to continue supporting NIH’s scientific mission through our biomedical and informatics expertise. Congratulations to Dr. Ho and your team!
August 27, 2024
Truvante Selected for NIH Entrepreneurship Program
Truvante is proud to announce that our project in support of children’s mental health has been selected to participate in the NIH Entrepreneurship Program. We appreciate NIH’s recognition and support of our commitment to innovation for health-focused initiatives. If you are interested in joining the effort, please contact us through this survey or using the contact form.